[PDF] UK Grievance Policy - AstraZeneca

• Skip to content
• Skip to navigation
• Skip to footer

Search Menu Search Search Search Close

• What science can do What science can do
  • Stories of impact
  • Publications
  Close
• R&D R&D
  • Our approach Our approach to R&D
    • STEM at AstraZeneca
  • Precision medicine
  • Transformative science
  • Data science & AI
  • Clinical innovation
  • Our technologies
  • Next generation therapeutics
  • R&D strategic centres
  Featured website AstraZeneca Clinical Trials Featured website Open Innovation Close
• Our therapy areas Our therapy areas
  • Oncology
  • BioPharmaceuticals
  • Cardiovascular, Renal and Metabolism
  • Respiratory & Immunology
  • Vaccines & Immune Therapies
  • Rare Disease
  • Pipeline
  • All medicines
  Close
• Our company Our company
  • Our history
  • Our people Our people
    • Oncology
    • BioPharmaceuticals
    • Rare Disease
    • Research & Development
    • Enabling functions
    • Operations
    • International
  • Our leadership
  • Cambridge
  • Gothenburg
  • Gaithersburg
  Close
• Careers Careers
  • Great place to work
  • Inclusion and diversity
  • Learning and development
  • Employee resource groups
  Close
• Investors Investor Relations (Global)
  • Investor Relations (Sweden)
  • Resources
  • Governance
  • Shareholder information
  • Dividend policy
  • Key facts
  • FAQs
  • Debt Investors
  • ADR Programme
  • Investor Relations contacts
  Feature Results and presentations Close
• Media Media
  • Press Releases
  • Articles
  • Image library
  • Archive
  • Media contacts
  Close
• Sustainability Sustainability
  • Climate change Climate change overview
    • Renewables
    • Product sustainability
    • AZ Forest
  • Nature Nature overview
    • Water stewardship
    • Pharmaceuticals in the environment
    • Waste and circularity
  • Health equity Health equity overview
    • Science
    • Healthcare delivery
    • Community investment
  • Health systems resilience Health systems resilience overview
    • Partnership for Health System Sustainability and Resilience (PHSSR)
  • Ethics and governance Ethics and Compliance
    • Governance
    • Sustainability governance
  • Our people Great place to work
    • Inclusion and diversity
    • Learning and development
    • Workforce safety and health
  • Our Values
  • Partnerships and alliances
  • Resources Sustainability resources
    • Our sustainability impact
  Feature Our sustainability impact Feature Sustainable science Close
• Partnering Partnering
  • Our business development teams
  • Our areas of partnering interest
  • Why partner with AstraZeneca?
  • Information for Suppliers
  • Supplier Sustainability Hub
  • Sustainable procurement
  • A Catalyst Network
  Close

• AstraZeneca Websites
• Global site

404 Error Sorry! The page you requested could not be found

Please use the search feature at the top of the page or visit one of the links below.

• Visit our home page
• Read our latest news
• Visit our investors section
• Find out more about careers with us
• Use our sitemap

You may wish to inform the webmaster of the site you came from that their link needs to be updated.

You are now leaving AstraZeneca.com

You have selected a link that will take you to a site maintained by a third party who is solely responsible for its contents.

AstraZeneca provides this link as a service to website visitors. AstraZeneca is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Click ‘cancel’ to return to AstraZeneca’s site or ‘continue’ to proceed.

Cancel Continue

Important notice for users You are about to access AstraZeneca historic archive material. Any reference in these archives to AstraZeneca products or their uses may not reflect current medical knowledge and should not be used as a source of information on the present product label, efficacy data or safety data. Please refer to your approved national product label (SmPC) for current product information. I have read this warning and will not be using any of the contained product information for clinical purposes.

I disagree I agree